Valve-in-Valve: High or Low Implantation for Better Outcomes?

Original Title: Transcatheter Replacement of Failed Bioprosthetic Valve. Large Multicenter Assessment of the Effect of Implantation Depth on Hemodynamics after Aortic Valve-in Valve.

Reference: Matheus Simonato, et al. Circ. Cardiovasc. Interv 2016;9:e003651

 

Courtesy of Dr. Carlos Fava.

 

valve_in_valveAt present, most patients undergoing surgical valve replacement receive a bioprosthetic valve, which lasts from 10 to 15 years. However, when it starts failing, reoperation is a high risk.

Transcatheter valve implantation inside a failed surgical bioprosthetic valve (V-in-V) could eventually solve this problem, but its evolution and exact implantation depth continues to raise questions.

The study analyzed 292 high risk consecutive patients form the International V-in-V (VIVID) registry.

The purpose of this study was to determine optimal implantation depth for the best hemodynamic outcome, defined as <20 mmHg gradient.

Mean age was 78.9 years with more than 90% patients with symptomatic dyspnea in FC III-IV. Bioprosthetic valves had failed approximately 10 after procedure, caused by:

  • stenosis, 40%
  • mixed factors, 35%
  • regurgitation, 25%

From the total number of patients, 157 received the CoreValve and 135 the Sapiens XT.

High implantation depth was associated to lower rates of post implantation elevated gradients compared to low implantation depth, and this was true for both valves:

CoreValve Evolut

  • High implantation depth 15%
  • Low implantation depth 34.2%

p=0.03

Sapiens XT

  • High implantation 18.5%
  • Low implantation 43.5%

p=0.03

Implantation depth was a strong predictor of post implantation gradient.

 

Conclusion

High implantation, both for CoreValve and Sapiens XT ─ inside a failed surgical valve ─ is a strong independent predictor of satisfactory hemodynamic outcomes.

 

Editorial Comment

V-in-V is a significantly less invasive strategy that solves stenosis or failure of bioprosthetic surgical valves.

To meet its increasing demand and optimize results requires that we master this implantation technique.

 

Courtesy of Dr. Carlos Fava. Favaloro Foundation, Buenos Aires, Argentina.

 

We value your opinion. You are more than welcome to leave your comments, thoughts, question or any ideas here below.

More articles by this author

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...